Table 2 Confounding variables
Confounder | Points of measurement | S-ketamine group | Control group | ||
|---|---|---|---|---|---|
Pain a | T1 | 4.00 ± 1.85 | 2.88 ± 2.10 | ||
T2 | 3.50 ± 1.77 | 2.88 ± 1.73 | |||
AEDL a | T1 | 14.50 ± 7.69 | 8.00 ± 4.63 | ||
T2 | 15.88 ± 7.70 | 9.38 ± 5.24 | |||
Psycho-oncological treatment (minutes) a | T1 | 53.75 ± 55.92 | 72.00 ± 60.47 | ||
T2 | 68.75 ± 68.86 | 124.50 ± 90.17 | |||
Days with antidepressants a | T1 | 2.38 ± 2.97 | 1.25 ± 1.83 | ||
T2 | 3.88 ± 4.12 | 2.88 ± 3.31 | |||
Palliative care treatment (days) a | T1 | 5.63 ± 2.88 | 3.38 ± 1.06 | ||
T2 | 8.00 ± 3.70 | 7.50 ± 2.45 | |||
Benzodiazepines b | T1 | yes | 6 | yes | 5 |
no | 2 | no | 3 | ||
T2 | yes | 6 | yes | 4 | |
no | 2 | no | 4 | ||
Antidepressants b | T1 | yes | 6 | yes | 3 |
no | 2 | no | 5 | ||
T2 | yes | 6 | yes | 5 | |
no | 2 | no | 3 | ||
Opioids b | T1 | yes | 8 | yes | 7 |
no | 0 | no | 1 | ||
T2 | yes | 8 | yes | 7 | |
no | 0 | no | 1 | ||